Michael Kenneth Ameriks - Publications

1996-2002 Chemistry Stanford University, Palo Alto, CA 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Maher MP, Wu N, Ravula S, Ameriks MK, Savall BM, Liu C, Lord B, Wyatt RM, Matta JA, Dugovic C, Yun S, Ver Donck L, Steckler T, Wickenden AD, Carruthers NI, et al. Discovery and characterization of AMPA receptor modulators selective for TARP-γ8. The Journal of Pharmacology and Experimental Therapeutics. PMID 26989142 DOI: 10.1124/jpet.115.231712  0.68
2015 Ameriks MK, Ao H, Carruthers NI, Lord B, Ravula S, Rech JC, Savall BM, Wall JL, Wang Q, Bhattacharya A, Letavic MA. Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 26707399 DOI: 10.1016/j.bmcl.2015.12.052  0.68
2015 Lord B, Ameriks MK, Wang Q, Fourgeaud L, Vliegen M, Verluyten W, Haspeslagh P, Carruthers NI, Lovenberg TW, Bonaventure P, Letavic MA, Bhattacharya A. A novel radioligand for the ATP-gated ion channel P2×7: [(3)H] JNJ-54232334. European Journal of Pharmacology. PMID 26386289 DOI: 10.1016/j.ejphar.2015.09.026  0.68
2015 Rudolph DA, Alcazar J, Ameriks MK, Anton AB, Ao H, Bonaventure P, Carruthers NI, Chrovian CC, De Angelis M, Lord B, Rech JC, Wang Q, Bhattacharya A, Andres JI, Letavic MA. Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists. Bioorganic & Medicinal Chemistry Letters. PMID 26099534 DOI: 10.1016/j.bmcl.2015.06.004  0.68
2011 Trost BM, O'Boyle BM, Torres W, Ameriks MK. Development of a flexible strategy towards FR900482 and the mitomycins. Chemistry (Weinheim An Der Bergstrasse, Germany). 17: 7890-903. PMID 21618622 DOI: 10.1002/Chem.201003489  0.68
2010 Ameriks MK, Bembenek SD, Burdett MT, Choong IC, Edwards JP, Gebauer D, Gu Y, Karlsson L, Purkey HE, Staker BL, Sun S, Thurmond RL, Zhu J. Diazinones as P2 replacements for pyrazole-based cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 4060-4. PMID 20541404 DOI: 10.1016/J.Bmcl.2010.05.086  0.68
2010 Lee-Dutra A, Wiener DK, Arienti KL, Liu J, Mani N, Ameriks MK, Axe FU, Gebauer D, Desai PJ, Nguyen S, Randal M, Thurmond RL, Sun S, Karlsson L, Edwards JP, et al. Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1. Bioorganic & Medicinal Chemistry Letters. 20: 2370-4. PMID 20153648 DOI: 10.1016/j.bmcl.2010.01.108  0.68
2010 Venable JD, Ameriks MK, Blevitt JM, Thurmond RL, Fung-Leung WP. Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease. Recent Patents On Inflammation & Allergy Drug Discovery. 4: 1-15. PMID 20017720 DOI: 10.2174/187221310789895603  0.68
2009 Ameriks MK, Cai H, Edwards JP, Gebauer D, Gleason E, Gu Y, Karlsson L, Nguyen S, Sun S, Thurmond RL, Zhu J. Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potency. Bioorganic & Medicinal Chemistry Letters. 19: 6135-9. PMID 19783435 DOI: 10.1016/j.bmcl.2009.09.013  0.68
2009 Ameriks MK, Axe FU, Bembenek SD, Edwards JP, Gu Y, Karlsson L, Randal M, Sun S, Thurmond RL, Zhu J. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements. Bioorganic & Medicinal Chemistry Letters. 19: 6131-4. PMID 19773165 DOI: 10.1016/j.bmcl.2009.09.014  0.68
2009 Ameriks MK, Venable JD. Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma. Current Topics in Medicinal Chemistry. 9: 738-53. PMID 19689378 DOI: 10.2174/156802609789044434  0.68
2004 Trost BM, Ameriks MK. Pd-catalyzed carbonylative lactamization: a novel synthetic approach to FR900482. Organic Letters. 6: 1745-8. PMID 15151404 DOI: 10.1021/Ol049583Y  0.68
1997 Taylor RE, Ameriks MK, LaMarche MJ. A novel approach to oligocyclopropane structural units Tetrahedron Letters. 38: 2057-2060. DOI: 10.1016/S0040-4039(97)00284-0  0.68
Show low-probability matches.